James Burt

Sales & Marketing

James Burt, CEO of Pharmanovia, is a seasoned leader focused on driving innovation in the value-added medicines (VAMs) space.

News

Zymeworks has reached a deal to buy Theravance, claiming rights to COPD therapy Yupelri, sold by Viatris, which made $267m last year.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.